An Expanded Access Program of Pegfilgrastim (Neulastim) in Participants With Non-Hodgkin's Lymphoma (NHL)

NCT02782845 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

53

Enrollment

INDUSTRY

Sponsor class

Conditions

Non-Hodgkin's Lymphoma

Interventions

DRUG: Chemotherapy
DRUG: Immunochemotherapy
DRUG: Pegfilgrastim

Sponsor

Hoffmann-La Roche